To access this element change to forms mode OFF
Grant Award View - GA201593
Interstitial lung disease: Improving patient outcomes through risk...
GA ID:
GA201593
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
19-Aug-2021
Publish Date:
10-Nov-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2026
Value (AUD):
$715,814.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Investigator Grants
Grant Activity:
Interstitial lung disease: Improving patient outcomes through risk prediction and disease burden management
Purpose:
Interstitial lung diseases (ILD) are complex incurable lung scarring conditions, which cause distressing breathlessness, fatigue, and poor quality of life. It is the second most common cause of death due to chronic lung disease in Australia. My program will allow us to predict how the disease worsens over time, to understand how sleep and drug complexity affect health outcomes, and to better treat debilitating shortness of breath and low oxygen levels in people with ILD.
GO ID:
GO Title:
Investigator Grants 2021
Internal Reference ID:
2021/GNT2008255
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
Institute for Breathing and Sleep
Recipient ABN:
39 093 685 879
Grant Recipient Location
Suburb:
Heidelberg
Town/City:
Heidelberg
Postcode:
3084
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC, Overseas
Postcode:
Multiple
Country:
AUSTRALIA, CANADA